Skip to content

The SLEEP-CARE Study

Explore the Effects of SLEEP Deprivation on Short-term Outcomes in ICU pAtients basEd on polysomnogRaphy:a Single-center Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06336408
Enrollment
80
Registered
2024-03-28
Start date
2024-02-01
Completion date
2025-12-31
Last updated
2024-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance

Keywords

Polysomnography, intensive care unit

Brief summary

Sleep disorder is common in ICU patients, such as reduced sleep time, fragmentation, and abnormal sleep rhythm. In 2023, American Thoracic Society released a research statement on sleep and circadian disruption(SCD) in ICU, which considered SCD is an important potential target for improving critical illness outcomes. Although polysomnography(PSG) is the gold standard of sleep measurement, subjective sleep evaluation tools are still used in most clinical studies related to sleep in ICU. This makes the sleep quality of ICU patients overestimated and difficult to reflect their true sleep conditions. And the answers to how and which outcomes different levels of sleep deprivation affect patient outcomes are still unclear and need to be further explored.

Interventions

None listed

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults (≥ 18-years old) * anticipated SICU stay for 24 hours or more

Exclusion criteria

* pregnancy * Have a clear history of medication for sleep disorders * History of mental or psychological illness * Treated with CRRT or ECMO during monitoring

Design outcomes

Primary

MeasureTime frameDescription
Compound outcome indexDischarge from ICU or 2 weeksPatients with cognitive, respiratory, digestive, cardiovascular, or immune-related adverse outcomes. Cognitive-related adverse outcomes were defined as delirium in the ICU(using Confusion Assessment Method Intensive Care Unit to screen delirium as negative or positive). Respiratory-related adverse outcomes was defined as a decrease in blood gas oxygenation index below 300mmHg in ICU. Gastrointestinal related adverse prognosis was defined as bleeding from stress ulcer in ICU. Cardiovascular-related adverse outcomes were defined as newly diagnosed heart failure, arrhythmia, and myocardial infarction in ICU. Immune-related poor prognosis defined SOFA (Sequential Organ Failure Assessment) scores increased by more than 2 points compared to the time of entry.

Secondary

MeasureTime frameDescription
LOSThrough study completion, an average of 10 dayslength of ICU stay

Countries

China

Contacts

Primary ContactJingjing Li, Master
li.jingjing@zs-hospital.sh.cn13512106878

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026